News & Events
March 10, 2017
Mobile Devices in Clinical Trials for Neurological Diseases: CDISC Standards DevelopmentMarch 10, 2017 Pointe Hilton Tapatio Cliffs Resort | Phoenix, AZ Overview and Objectives The Coalition Against Major Diseases (CAMD), a consortium within the Critical Path Institute, is focused on accelerating the regulatory sciences required to advance innovative treatments for Alzheimer Disease and related neurodegenerative diseases with impaired cognition and function. In collaboration with......
October 12, 2016
Coalition Against Major Diseases 2016 Annual Regulatory Science WorkshopOctober 12, 2016 College Park Marriott Hotel and Conference Center, Hyattsville, Maryland SPONSORED BY: Critical Path Institute MEETING MINUTES [PDF] (Presentations are linked in the agenda, below.) Overview and Objectives The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase......
March 31, 2016 - April 1, 2016
CAMD Digital Biomarkers ConferenceUse of Biosensors in Clinical Trials: Barriers & Solutions to the Current Landscape March 31 – April 1, 2016 Bethesda North Marriott Conference Center Interest in identifying, evaluating and qualifying innovative technologies for use in drug development is growing. While regulatory guidance documents exist for pursuing novel Drug Development Tools (DDTs) and Medical Devices Development......
October 15, 2015
Coalition Against Major Diseases and FDA 2015 Annual Scientific WorkshopOctober 15, 2015 FDA White Oak Campus CO-SPONSORED BY: Critical Path Institute U.S. Food and Drug Administration Overview and Objectives The Coalition Against Major Diseases (CAMD) is a public-private-partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process of new treatments for Alzheimer’s disease......
- August 21, 2015